Biotechnology company and medical laboratory, born as spin-off of the National Research Council (CNR) in Bologna.
Specialized in membrane lipidomics and Cell Membrane Science applied to personalized health.
Proprietary analytical method MEM_LIP1 accredited according to ISO/IEC 17025.
Lipinutragen Srl is a biotechnology company and medical laboratory based in Bologna (Italy), founded in 2005 as a spin-off of the National Research Council (CNR).
Guided by the concept of Cell Membrane Science, Lipinutragen translates scientific research on membrane lipidomics into practical tools supporting personalized health and nutrition strategies.
The company performs molecular analysis of cell membrane fatty acids, focusing on the lipid composition of mature red blood cells. This approach provides objective information on the interaction between nutrition, metabolism and cellular function.
Lipinutragen operates a medical lipidomics laboratory authorized by the Italian Health Authority (ASL). The analytical workflow integrates proprietary robotic technology for automated mature erythrocyte selection and membrane lipid extraction, ensuring high analytical reproducibility and reliability.
The analytical method MEM_LIP1, used for membrane lipidomic profiling, is validated and accredited according to ISO/IEC 17025, confirming the scientific robustness and quality of the analytical process.
Lipinutragen’s scientific foundations originate from the research of Dr. Chryssostomos Chatgilialoglu and Dr. Carla Ferreri, internationally recognized scientists in membrane lipidomics.
Today Lipinutragen integrates molecular diagnostics, research, nutraceutical innovation and professional training, providing healthcare professionals with advanced tools to support personalized health strategies.
Core activities
• Membrane lipidomic analysis and molecular diagnostics
• Nutrilipidomics and personalized nutrition strategies
• Scientific research and technology development
• Training and education for

Lipinutragen

Org chart

Teams

Offices